Drugs Made In America Acquisition II Corp. Liquidation Value
DMII
Other
Cash & Equivalents
$223
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $223
Total Obligations: -$300,864
$-300,641
Per share: $-0.02
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $223
AR: $0
Total Obligations: -$300,864
$-300,641
Per share: $-0.02
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $223
AR: $0
Inventory: $0
Total Obligations: -$300,864
$-300,641
Per share: $-0.02
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-300,641 | $-0.02 |
| Liquid Liquidation Value | $-300,641 | $-0.02 |
| Operating Liquidation Value | $-300,641 | $-0.02 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $223 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $300,864 |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 13.7M |
Explore all 59 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $223 | N/A | N/A | $99,359 | $300,864 | N/A | N/A | N/A |
| 2025-09-30 | $630,174 | N/A | N/A | $4,592 | $677,345 | N/A | N/A | N/A |
| 2024-12-31 | $34,070 | N/A | N/A | N/A | $254,783 | N/A | N/A | N/A |
| 2024-09-30 | $120,070 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes